Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

75

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

75 results for “Moringa”

Learn how ShareScore rates datasets ↗
zenodo32/100

Fig. 3 in Biochemical and molecular insights of PGPR application for the augmentation of carotenoids, tocopherols, and folate in the foliage of Moringa oleifera

Fig. 3. HPLC Chromatograms of 1- Violaxanthin, 2- Lutein, 3- Chl b, 4-Chl a, 5- β-carotene in control and GBO3- B. subtilis GB03 treated M. oleifera foliage.

opennotspecifiedNov 2020View details →
zenodo32/100

Fig. 5 in Biochemical and molecular insights of PGPR application for the augmentation of carotenoids, tocopherols, and folate in the foliage of Moringa oleifera

Fig. 5. Differential expression of mRNA levels of γ-tocopherol methyltransferase (γ-TMT), phytoene synthase (PSY), phytoene desaturase (PDS), lycopene β-cyclase (LBC) and dihydrofolate reductase thymidylate (DHFR-TS) in M. oleifera foliage after treatment with GB03-B. subtilis GB03, T4-B. pumilus T4, COM1- Combination 1, COM2- Combination 2, COM3-Combination 3. Experiments were repeated three times, each with three replicates. Columns without a common lowercase letter indicate significantly different values among treatments based on Tukey's test (P value ≤ 0.05).

opennotspecifiedNov 2020View details →
zenodo32/100

Fig. 2 in Biochemical and molecular insights of PGPR application for the augmentation of carotenoids, tocopherols, and folate in the foliage of Moringa oleifera

Fig. 2. HPLC Chromatograms of 1- δ-tocopherol, 2- γ-tocopherol and 3- α-tocopherol in control, 937a- B. amyloliquefaciens IN937a and SE34- B. pumilus SE34 treated M. oleifera foliage.

opennotspecifiedNov 2020View details →
zenodo32/100

Fig. 1. M. oleifera treated with 1 in Biochemical and molecular insights of PGPR application for the augmentation of carotenoids, tocopherols, and folate in the foliage of Moringa oleifera

Fig. 1. M. oleifera treated with 1) B. amyloliquefaciens IN937a, 2) B. subtilis IN937b, 3) Brevibacillus brevis IPC 11, 4) B. subtilis GB03, 5) B. pumilus INR7, 6) B. pumilus SE34, 7) B. pumilus T4, 8) P. fluorescens UOM14 shown compared to control.

opennotspecifiedNov 2020View details →
zenodo32/100

weight gain and nutrient utilization performances of tropical goats feed moringa leaves with cafeteria leftover

<p>Abstract</p> <p><strong>Background</strong>: Dairy cattle feed supplies in the tropics, and particularly in Ethiopia, are mostly derived from base diets (natural and improved grasslands, agricultural wastes, fodder trees and shrubs), agro-industrial by-products, and non-conventional feeds. The availability of major feed resource kinds, sources, and dairy cattle feeding practises are primarily influenced by agro-ecology and season, as well as their interactions.</p> <p><strong>Objectives</strong>: The research was carried out in the Chencha district of Gamo Zone, Southern Ethiopia, with the goals of assessing available, feeding system, opportunity, limits, and copying strategy of dairy cattle production, as well as estimating feed balance.</p> <p><strong>Methods</strong>: Data was gathered through primary and secondary data sources, field observations, key informant interviews, focus group talks, and individual interviews. The survey data was stratified into altitudes, coded, and analysed using the Statistical Package for Social Sciences version 20 and the general linear model approach. Cross tabulation was used to examine the statistical variance of categorical data.</p> <p><strong>Results:</strong> The presence of different feed resource types, distinct agro-ecologies (P &lt; 0.05), and crop residue accessibility were the major opportunities for dairy cattle production in the study district, but land scarcity, a lack of dry season forages, and land degradation due to erosion were the major constraints for dairy cattle feed production. In the research district, the main feed resource copying approaches were reducing the number of dairy animals, saving optional feeds, and purchasing optional feeds. The total mean of dairy cow feed supply to TLU in terms of DM production each year was 3.86 tonnes of DM/HH/annual, with a negative feed balance of 8.09 tonnes that varied with seasons and agro-ecology (P &lt; 0.05).</p> <p><strong>Conclusions:</strong> According to the findings of this study, the low production of dairy cattle in the district is clearly related to the scarcity of feed resources. To address these issues, alternative feed production technologies should be implemented, such as farmers practising forage development on their own crop land and collecting crop residues during crop harvesting times and storing them under shed, the nutritive value of different types of fodder trees and shrubs should be further determined in the future, and feed storage methods, particularly hay and silage, should be used when there are an abundance of feed resources available.</p>

opencc-by-4.0Aug 2023View details →
ClinicalTrials.gov32/100

Evaluation of Moringa Oleifera Leaf Extract Versus Sodium Hypochlorite in Pulpectomy of Nonvital Primary Molars

ClinicalTrials.gov study NCT06948526. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients

ClinicalTrials.gov study NCT06125873. IPD Sharing: NO. Countries: 1. Publications: 8.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Moringa Oleifera Capsule in Increasing Breast Milk Volume in Early Postpartum Patients

ClinicalTrials.gov study NCT04487613. IPD Sharing: NO. Countries: 1. Publications: 9.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Moringa Powder Acceptability Trial Among Healthy Adults

ClinicalTrials.gov study NCT05861076. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Moringa Oleifera Dehydrated Leaf Powder on the Components of Metabolic Syndrome in Mexican Adults.

ClinicalTrials.gov study NCT07194577. IPD Sharing: NO. Countries: 1. Publications: 9.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Moringa Oleifera Mouthwash

ClinicalTrials.gov study NCT05191069. IPD Sharing: NO. Countries: 1. Publications: 8.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Effects of Moringa Oleifera Leaves on Glycemia, Lipemia and Inflammatory Profile in Prediabetic Patients

ClinicalTrials.gov study NCT04734132. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Moringa Oleifera Infusion on Health

ClinicalTrials.gov study NCT04314258. IPD Sharing: YES. Countries: 1. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Remineralization Efficacy of Moringa Oleifera Varnish Vs MI Varnish in Initial Carious Lesions Over 6 Months Follow Up: a Randomized Controlled Clinical Trial

ClinicalTrials.gov study NCT06905379. IPD Sharing: NO. Countries: 1. Publications: 9.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Effects of Allium Sativum and Moringa Oleifera Extract on Dental Enamel

ClinicalTrials.gov study NCT05744752. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Evaluation of Artemisia Annua and Moringa

ClinicalTrials.gov study NCT03366922. IPD Sharing: NO. Countries: 1. Publications: 4.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Moringa Oleifera on Bone Density

ClinicalTrials.gov study NCT03026660. IPD Sharing: NO. Countries: 1. Publications: 7.

closedIPD-NOFeb 2026View details →
zenodo28/100

Figure 3 from: Laksmiani NPL, Widiantara IWA, Pawarrangan ABS (2022) Potency of moringa (Moringa oleifera L.) leaves extract containing quercetin as a depigmentation agent inhibiting the tyrosinase enzyme using in-silico and in-vitro assay. Pharmacia 69(1): 85-92. https://doi.org/10.3897/pharmacia.69.e73132

Figure 3 The interaction of hydrogen bonds between the target protein of the tyrosinase with kojic acid. a: docking conformation kojic acid to tyrosinase, b: 3D interaction visualization of tyrosinase amino acid residues with kojic acid, c: 2D interaction visualization of tyrosinase amino acid residues with kojic acid.

opencc-by-4.0Jan 2022View details →
zenodo28/100

Figure 5 from: Laksmiani NPL, Widiantara IWA, Pawarrangan ABS (2022) Potency of moringa (Moringa oleifera L.) leaves extract containing quercetin as a depigmentation agent inhibiting the tyrosinase enzyme using in-silico and in-vitro assay. Pharmacia 69(1): 85-92. https://doi.org/10.3897/pharmacia.69.e73132

Figure 5 TLC-chromatogram of Moringa Leaves extract at UV 254 nm (A) and UV 366 nm (B). Quercetin standard 100, 200, 400, 800, 1600 and 3200 ng (1–6); Moringa Leaves Maceration extract (7); reflux extract (8), soxhlation extract (9); quercetin standard 800 ng (10–11); UV spectrum of spot with Rf 0.4 from quercetin standard (C); UV spectrum of spot with Rf 0.4 from maceration extract of Moringa Leaves (D); UV spectrum of spot with Rf 0.4 from soxhlation extract of Moringa Leaves (E).

opencc-by-4.0Jan 2022View details →
zenodo28/100

Figure 1 from: Laksmiani NPL, Widiantara IWA, Pawarrangan ABS (2022) Potency of moringa (Moringa oleifera L.) leaves extract containing quercetin as a depigmentation agent inhibiting the tyrosinase enzyme using in-silico and in-vitro assay. Pharmacia 69(1): 85-92. https://doi.org/10.3897/pharmacia.69.e73132

Figure 1 Redocking visualization between tyrosinase enzyme and native ligand. 1: The structure of the tyrosinase enzyme (PDB ID: 2Y9X), 2a: tyrosinase enzyme structure without native ligand, 2b: native ligand (tropolone) structure, 3a: redocking conformation, 3b: 3D interaction of amino acid residues from tyrosinase enzyme with native ligand, 3c: 2D interaction of amino acid residues from tyrosinase enzyme with native ligand.

opencc-by-4.0Jan 2022View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record